Leidos · 13 hours ago
USELMS Database Analyst
Leidos is looking for a motivated analyst with a passion for Electronic Warfare and technical data. In this role, you’ll support the 57th Intelligence Squadron by helping build, verify, and improve the United States Electromagnetic Systems (USELMS) database, which is critical for the EW and Intelligence Community.
ComputerGovernmentInformation ServicesInformation TechnologyNational SecuritySoftware
Responsibilities
Review and assess USELMS data for Radar, EO/IR, Communications, ECM, RWR, and platform systems
Perform quality checks on engineering models and technical intelligence to ensure accuracy
Document findings and support government acceptance decisions
Help standardize processes and improve workflows across IMD Production Centers
Analyze U.S. and own-forces electromagnetic systems
Support Foreign Disclosure Officer (FDO) reviews for releasable models
Provide updates to NATO emitter databases (Radar/Comms)
Track and resolve Data Quality Feedback (DQF) reports
Manage Blue/White data requests in AIRES, including agency coordination and timeline forecasting
Identify process improvements and support data-integration modernization efforts (e.g., APIs)
Qualification
Required
Bachelor's degree in Electrical Engineering, Radar Engineering, Physics, or related field. Additional related experience may substitute for a degree
Active Secret clearance; ability to obtain TS/SCI
3+ years of analytical or technical experience
Background in EW, Intelligence Community, EMS, or IMD production
Strong communication skills and ability to work independently
Preferred
Familiarity with USELMS schemes (Radar, Comms, ECM, EO/IR, RWR, Platforms)
Experience with CUI handling and security markings
Exposure to Nighthawk or similar analytical tools
Knowledge of radar systems, Technical ELINT, or system operations/maintenance
Benefits
Health and Wellness programs
Income Protection
Paid Leave
Retirement
Company
Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world’s most vexing challenges in national security and health.
Funding
Current Stage
Public CompanyTotal Funding
unknown2025-02-20Post Ipo Debt
2013-09-17IPO
Recent News
MarketScreener
2025-12-16
2025-12-16
Company data provided by crunchbase